Solara Active Pharma Sciences Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Vishal Mathur, was filed 25 Jun 2025.
Solara Active Pharma Sciences Limited: what insiders have been doing
Every trade that managers of Solara Active Pharma Sciences Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. 1 insider has disclosed 1 filing since 18 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Over the last twelve months, not one insider purchase of Solara Active Pharma Sciences Limited stock was filed.
Compared with its exchange (1,890 companies, median 4 filings), a count of 1 filing is below the norm. Over the whole record (from 2021), the tally stands at 48 purchases and 26 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- +3.6%Entry ₹620.80 · Close at T+90 ₹643.15
- +28.7%Entry ₹524.75 · Close at T+90 ₹675.45
- +39.7%Entry ₹475.70 · Close at T+90 ₹664.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 2,000,000 sharesEquity SharesAcquisition of shares - Encumbrance CreationSEBI:7c2e5bcc01a6ae269261aaf4ac86e7265fb17144
- 10,000 shares@ ₹631.8868.0% of flowEquity SharesSEBI:ff2dc55f3d9f098f4c64342195b6cfd793016690
- 4,823 shares@ ₹612.679932.0% of flowEquity SharesSEBI:0b44020e56585aa40e0a98f5bc6ad6ebbf351807
- 5,473 shares@ ₹544.2967100.0% of flowEquity SharesSEBI:441863af962181f182cdbc139ca4cf44103f2a4fCanonical exit: 21 Sept 2025 (T+90)
- 2,000,000 shares@ ₹495.0078.7% of flowEquity SharesSEBI:5561d107e3fe7dd13f76ee9c109e8a5b27525840Canonical exit: 14 Sept 2025 (T+90)
- 1,000 shares@ ₹473.99100.0% of flowEquity SharesSEBI:e955b8d23055a96fa9dd6e37a0bdad34c94ef96eCanonical exit: 2 Sept 2025 (T+90)
- 1,000 shares@ ₹500.056100.0% of flowEquity SharesSEBI:0be526db765cdbd6ffe4a9b2462b8c2b807e482aCanonical exit: 9 Jun 2025 (T+90)
- 13,600 shares@ ₹461.49860.5% of flowEquity SharesSEBI:e1ad745abe82593cdeaba2d104222b6efe00dc2eCanonical exit: 29 May 2025 (T+90)
- 152,156 shares@ ₹473.47616.2% of flowEquity SharesSEBI:d3a8c35cc12c55a8191c49cf0b7be5b830346d91Canonical exit: 25 May 2025 (T+90)
- 216,361 shares@ ₹474.30538.9% of flowEquity SharesSEBI:4e8531ceb8d5ff051835eadf0ce5d4bbaa27eebcCanonical exit: 22 May 2025 (T+90)
- 34,000 shares@ ₹524.82461.6% of flowEquity SharesSEBI:a08383d14706782236e2d1d987fb08bdcfd027f7Canonical exit: 5 May 2025 (T+90)
- 78,000 shares@ ₹516.68333.5% of flowEquity SharesSEBI:d72d96c029d773987f18813d7ce4dc93cfbe7bc3Canonical exit: 2 May 2025 (T+90)
- 3,000 shares@ ₹808.30100.0% of flowEquity SharesSEBI:fa2de213b38db8d5e280197aa4625831567fece5Canonical exit: 24 Dec 2024 (T+90)
- 2,013,747 shares@ ₹339.650733.2% of flowEquity SharesSEBI:48d4ed0af834f2ba94d1f7efa6a4c6096cdae8b6
- 92,228 shares@ ₹333.0721100.0% of flowEquity SharesSEBI:72e9d64b5e3aa53cb2b6753c145511be0f239935
- 272,181 shares@ ₹334.215845.2% of flowEquity SharesSEBI:a03ce07710d9c4c5a2d1411e82d50a3c49503e3c
- 35,591 shares@ ₹335.1161.0% of flowEquity SharesSEBI:99957a4b0cde3632981550f76e847462c1151252
- 736,253 shares@ ₹365.623722.8% of flowEquity SharesSEBI:9121408c8c9b780454de0d67a2535319cec93be6
- 500 shares@ ₹366.1162.4% of flowEquity SharesSEBI:e1cf4722c25a7549179aa4900b7f15effaafb34c
- 200,000 shares@ ₹369.6756.2% of flowEquity SharesSEBI:3f978b617cbd34e7d7de336b223052436d9403df
- 200,000 shares@ ₹372.47536.3% of flowEquity SharesSEBI:c0e8417d90df40135b275b093ed831797c2f5151
- 100 shares@ ₹369.000.5% of flowEquity SharesSEBI:058bec8b598aefa62ad7086b5aaddf1d6d6e86fc
- 3,000 shares@ ₹371.88914.5% of flowEquity SharesSEBI:e614908ab6fcefc1655b16d3c491a46e87142548
- 14,826 shares@ ₹369.2906100.0% of flowEquity SharesSEBI:c45c21f5c155196665188c3997a7a32fb605aaf7
- 200,000 shares@ ₹366.65076.2% of flowEquity SharesSEBI:60a31ba25b894327d167b9779b5c0d76c7ca45cc
25 of 124 declarations
About Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited is a company focused on the manufacturing of pharmaceutical products. It operates in the XBOM market and specializes in developing active solutions for the healthcare industry.
